Breast cancer drug may help thousands more women than previously thought

Thousands more women with breast cancer could benefit from a blockbuster immunotherapy drug than previously thought, research suggests.

They trialled the drug on women with early-stage breast cancer that is at high risk of recurring or spreading further, and that is oestrogen-receptor positive and HER2 negative.The Keynote-756 trial has been running internationally for eight years and comprises 1,278 patients with invasive ductal carcinoma , meaning cancer had started to spread out of the milk ducts and into the surrounding breast tissues.

About 24.3% of patients had no cancer cells remaining in the breast or lymph nodes compared with 15.6% of patients treated with a placebo.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Journalist Mary Lloyd’s personal story of breast cancerTrusted and independent source of local, national and world news. In-depth analysis, business, sport, weather and more.
Source: abc730 - 🏆 14. / 63 Read more »

Night shifts prompt change to sleep hormone found in breast milkBreastfeeding mothers working night shifts could produce milk with altered levels of melatonin, potentially affecting their child’s long-term health, new research suggests.
Source: theage - 🏆 8. / 77 Read more »

Night shifts prompt change to sleep hormone found in breast milkBreastfeeding mothers working night shifts could produce milk with altered levels of melatonin, potentially affecting their child’s long-term health, new research suggests.
Source: brisbanetimes - 🏆 13. / 67 Read more »